A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers

NCT02045524 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Urticaria

Interventions

OTHER: Deep muscle injection
OTHER: Sub-Q Injection

Sponsor

JDP Therapeutics, Inc.

Collaborators

[object Object]